Article
Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.
Cancer prevention research (Philadelphia, Pa.) - 1 Jan 2011
Dinh Tuan A, Rosner Benjamin I, Atwood James C, Boland C Richard, Syngal Sapna, Vasen Hans F A, Gruber Stephen B, Burt Randall W
Abstract excerpt
In current clinical practice, genetic testing to detect Lynch syndrome mutations ideally begins with diagnostic testing of an individual affected with cancer before offering predictive testing to at-risk relatives. An alternative strategy that warrants exploration involves screening unaffected individuals via demographic and family histories, and offering genetic testing to those individuals whose risks for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
